Search

Your search keyword '"Rosende-Roca, Maitée"' showing total 193 results

Search Constraints

Start Over You searched for: Author "Rosende-Roca, Maitée" Remove constraint Author: "Rosende-Roca, Maitée"
193 results on '"Rosende-Roca, Maitée"'

Search Results

1. Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort

2. Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia

3. Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

4. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

5. A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

6. Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort.

7. New insights into the genetic etiology of Alzheimer’s disease and related dementias

8. Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort

9. Psychological outcomes of dementia risk estimation in MCI patients: Results from the PreDADQoL project.

10. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

11. Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights

12. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

13. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results

14. Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

15. Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment

16. Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic

17. Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

18. Visual impairment in aging and cognitive decline: experience in a Memory Clinic

19. Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort

20. The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment

21. Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease

22. Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer’s Disease Dementia: A Latent Class Analysis

23. Intermediate and ExpandedHTTAlleles and the Risk for α‐Synucleinopathies

25. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

26. Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

27. From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery

28. Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies.

29. Biomarker-Based Risk Prediction of Alzheimer’s Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects

30. Estrogen receptor alpha gene variants are associated with Alzheimer's disease

31. Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes

32. Contributors

33. The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer’s Disease

34. Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic

35. Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.

36. MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium

37. ATP5H/KCTD2 locus is associated with Alzheimer's disease risk

38. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.

39. Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects

40. P2-283: An interdisciplinary portrait of dementia: The reality of barcelona, spain

41. O4-05-04: A four-center study on the effect of polygenic risk score on cerebrospinal fluid markers and memory decline in mild cognitive impairment patients

42. THE SPANISH VERSION OF FACE-NAME ASSOCIATIVE MEMORY EXAM (S-FNAME) PERFORMANCE IS RELATED TO AMYLOID BURDEN IN SUBJECTIVE COGNITIVE DECLINE

43. ARE THERE DIFFERENCES IN THE OPINION OF PATIENTS WITH ALZHEIMER DISEASE AND THEIR CAREGIVERS ABOUT HAVING SUPPORT FROM A SERVICE ROBOT AT HOME?

44. CORRELATIONS BETWEEN PLASMA AND BRAIN BETA-AMYLOID LEVELS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FUNDACIÓ ACE HEALTHY BRAIN INITIATIVE (FACEHBI)

45. EXPLORING APOE GENOTYPE EFFECTS ON AD RISK AND BETA-AMYLOID BURDEN IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FACEHBI STUDY RESULTS

46. Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer's Disease

48. Cognitive, Genetic, and Brain Perfusion Factors Associated with Four Year Incidence of Alzheimer's Disease from Mild Cognitive Impairment

49. O4-04-04: TOWARD FINE MAPPING AND FUNCTIONAL CHARACTERIZATION OF GENOME-WIDE ASSOCIATION STUDY-IDENTIFIED LOCUS RS74615166 (TRIP4) FOR ALZHEIMER'S DISEASE

50. P1‐046: ROLE OF PLD3 RARE VARIANTS IN EUROPEAN SPORADIC ALZHEIMER'S DISEASE PATIENTS

Catalog

Books, media, physical & digital resources